Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Inflammation Research, 2024
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels

Chen Y., Wang Z., Liang Y. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

MedComm, 2024
An inflammatory cytokine signature predicts IgA nephropathy severity and progression

Chen L., Chen X., Cai G. et al.

Olink Target 96NephrologyPatient StratificationUrine

European Heart Journal Open, 2024
Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug (NSAID) users

Vaja R., Ferreira P., Portas L. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologySerum

Genes & Immunity, 2024
The HLA-B –21 M/T dimorphism associates with disease severity in COVID-19

Strunz B., Momayyezi P., Bilev E. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Cell Metabolism, 2024
Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems

Goeminne L., Vladimirova A., Eames A. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Clinical Journal of the American Society of Nephrology, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins

Kobayashi H., Looker H., Ihara K. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologyPatient StratificationPlasma

Molecular Neurodegeneration, 2024
Proteomic analysis of APOEε4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience

Walker K., An Y., Moghekar A. et al.

Olink Target 96Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of Translational Medicine, 2024
Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features

Yang M., Yu H., Feng H. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

Journal of Gastroenterology and Hepatology, 2024
Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization

Zhu W., Fan C., Liu B. et al.

Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma

GeroScience, 2024
Plasma proteomics-based organ-specific aging for all-cause mortality and cause-specific mortality: a prospective cohort study

Zhao R., Lu H., Yuan H. et al.

Olink Explore 3072/384AgingPathophysiologyPatient StratificationPlasma

International Journal of Molecular Sciences, 2024
Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy

Cristiani C., Calomino C., Scaramuzzino L. et al.

Olink Target 96NeurologyPatient StratificationSerum

Gut Microbes, 2024
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study

Wang Y., Chen J., Ni Y. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Journal of Advanced Research, 2024
Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: A prospective cohort study

Zheng Y., Li J., Li Y. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma

Molecular Psychiatry, 2024
Whole exome sequencing identified six novel genes for depressive symptoms

Li Z., Fei C., Yin R. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of Translational Medicine, 2024
Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis

Jiang Y., Wang Y., Guo J. et al.

Olink Explore 3072/384Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPlasma

European Journal of Heart Failure, 2024
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts

Dieden A., Girerd N., Ottosson F. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of Translational Autoimmunity, 2024
Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for juvenile idiopathic arthritis

Cai Y., Chen X., Zheng D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Science Immunology, 2024
Gastrointestinal germinal center B cell depletion and reduction in IgA + plasma cells in HIV-1 infection

Cossarini F., Shang J., Krek A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Nature Communications, 2024
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials

Silverberg J., Rosmarin D., Chovatiya R. et al.

Olink Explore 3072/384Dermatological DiseasesPathophysiologySerum

Scientific Reports, 2024
Proteomic and serological markers for diagnosing cardia gastric cancer and precursor lesions in a Chinese population

Li J., Zhao W., Yang J. et al.

Olink Target 96OncologyPatient StratificationPlasma

3119 publications